Syndicate this blog
RSS feed

Archives
November 2006

BioMS Medical Begins Enrollment for Relapsing Remitting Multiple Sclerosis Drug Study

BioMS Medical Begins Enrollment for Relapsing Remitting Multiple Sclerosis Drug Study
Posted 2006-11-24 12:51:06
EDMONTON, Canada | Nov 23, 2006 | BioMS Medical Corp (TSX: MS), a leading developer in the treatment of multiple sclerosis (MS), today announced that the first patients have been enrolled in its placebo controlled multi-center Phase II clinical trial of MBP8298 for the treatment of relapsing remitting multiple sclerosis (RRMS).
Share this link?   Digg!Digg   RedditReddit   del.icio.usDel.icio.us   

Please send sugestions and comments to Kevin Rosenberg, M.D..